Felix Nikels Boehringer Ingelheim

Felix Nikels, Boehringer Ingelheim, Senior Principal Scientist in Analytical Development Pharmacist by training with an academic research background in biochemical pharmacology and functional drug characterization. Moving back to the industry in 2016 in the field of drug product analytics. As an expert in aggregate formation, particle analytics and control strategies currently support a broad range of therapeutic modalities, from therapeutic proteins and peptides over small molecules to virus-based therapeutics and gene therapies Member (including leadership roles) of several industry consortia and scientific working groups, e.g., under the umbrella of EFPIA, IQ, AAPS